Literature DB >> 21420396

Potential role of GABAA receptor subunit; GABRA6, GABRB2 and GABRR2 gene polymorphisms in epilepsy susceptibility and pharmacotherapy in North Indian population.

Ritu Kumari1, Ram Lakhan, J Kalita, R K Garg, U K Misra, Balraj Mittal.   

Abstract

BACKGROUND: GABA(A) receptors influence the susceptibility to seizures, and variations in the receptor genes can contribute to antiepileptic drug resistance also.
METHODS: We investigated the possible associations of single nucleotide polymorphisms (SNPs) present in GABRA6 c. 1512 T>C, GABRB2 c. 1412 C>T, and GABRR2 c. IVS2C>G genes of GABA(A) receptors in epilepsy susceptibility and drug resistance in northern Indian patients with epilepsy. After screening a total of 202 healthy controls and 401 epilepsy patients were enrolled in study. The genotyping was done by PCR-RFLP methods.
RESULTS: The GABRA6 c. 1512 T>C, polymorphism was conferring risk for epilepsy susceptibility for TC (P=0.018), CC (P=0.0001) genotype and for C allele (P=0.0002). Another polymorphism GABRB2 c. 1412 C>T was also conferring high risk for epilepsy susceptibility CT (P=0.012), TT (P=0.778) genotype and for variant T allele (P=0.034) but was not associated with drug resistance. No association was found with epilepsy susceptibility or with drug resistance in case of GABRR2 c. IVS2C>G gene polymorphism.
CONCLUSION: Overall, our findings suggest significant involvement of alpha (GABRA6) and beta (GABRB2) subunits of GABA(A) receptor in epilepsy susceptibility in north Indian population.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420396     DOI: 10.1016/j.cca.2011.03.018

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Genetic Polymorphism of GABRR2 Modulates Individuals' General Cognitive Ability in Healthy Chinese Han People.

Authors:  Zhe Ma; Binbin Niu; Zhangyan Shi; Junlin Li; Jian Wang; Fuchang Zhang; Xiaocai Gao; Kejin Zhang
Journal:  Cell Mol Neurobiol       Date:  2016-02-27       Impact factor: 5.046

2.  Impact of GABAA receptor gene variants (rs2279020 and rs211037) on the risk of predisposition to epilepsy: a case-control study.

Authors:  Maryam Amjad; Atiya Tabassum; Khalid Sher; Suneel Kumar; Sitwat Zehra; Sehrish Fatima
Journal:  Neurol Sci       Date:  2022-02-12       Impact factor: 3.307

3.  Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism.

Authors:  S Hossein Fatemi; Teri J Reutiman; Timothy D Folsom; Oyvind G Rustan; Robert J Rooney; Paul D Thuras
Journal:  J Autism Dev Disord       Date:  2014-08

Review 4.  Variable Expression of GABAA Receptor Subunit Gamma 2 Mutation in a Nuclear Family Displaying Developmental and Encephalopathic Phenotype.

Authors:  Gerald Nwosu; Shilpa B Reddy; Heather Rose Mead Riordan; Jing-Qiong Kang
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

5.  No association of GABRA1 rs2279020 and GABRA6 rs3219151 polymorphisms with risk of epilepsy and antiepileptic drug responsiveness in Asian and Arabic populations: Evidence from a meta-analysis with trial sequential analysis.

Authors:  Tiejun Zhang; Yi Yang; Xiutian Sima
Journal:  Front Neurol       Date:  2022-09-14       Impact factor: 4.086

6.  In Silico Prediction of Gamma-Aminobutyric Acid Type-A Receptors Using Novel Machine-Learning-Based SVM and GBDT Approaches.

Authors:  Zhijun Liao; Yong Huang; Xiaodong Yue; Huijuan Lu; Ping Xuan; Ying Ju
Journal:  Biomed Res Int       Date:  2016-08-08       Impact factor: 3.411

7.  GABRB2 Haplotype Association with Heroin Dependence in Chinese Population.

Authors:  Yung Su Kim; Mei Yang; Wai-Kin Mat; Shui-Ying Tsang; Zhonghua Su; Xianfei Jiang; Siu-Kin Ng; Siyu Liu; Taobo Hu; Frank Pun; Yanhui Liao; Jinsong Tang; Xiaogang Chen; Wei Hao; Hong Xue
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

8.  Novel and de novo mutations in pediatric refractory epilepsy.

Authors:  Jing Liu; Lili Tong; Shuangshuang Song; Yue Niu; Jun Li; Xiu Wu; Jie Zhang; Clement C Zai; Fang Luo; Jian Wu; Haiyin Li; Albert H C Wong; Ruopeng Sun; Fang Liu; Baomin Li
Journal:  Mol Brain       Date:  2018-09-05       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.